Barclays Starts Acceleron Pharma (XLRN) at Overweight
Tweet
Share
E-mailGet Alerts XLRN Hot Sheet
Price: $178.75 --0%
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Rating Summary:
11 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Join SI Premium – FREE
Barclays initiated coverage on Acceleron Pharma (NASDAQ: XLRN) with an Overweight rating and a price target of $40.00.
For an analyst ratings summary and ratings history on Acceleron Pharma click here. For more ratings news on Acceleron Pharma click here.
Shares of Acceleron Pharma closed at $31.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Internet Initiative Japan Inc (3774:JP) (IIJIY) at Neutral
- Barclays Upgrades ASOS Plc. (ASC:LN) (ASOMY) to Equalweight
- Barclays Reiterates Overweight Rating on Wizz Air Holdings (WIZZ:LN) (WZZAF)
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
